We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cancer Immunology – News and Features


Age-Related Cell Changes Promote Pancreatic Cancer Growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, according to research.
Melanoma cells, with different proteins tagged in yellow, blue, green and red.

Promising Cell Therapy Target Has Strong Response Against Melanoma

A new CAR T-cell therapy that targets cells with high levels of TYRP1 has shown promise against melanoma in preclinical trials.
Cancer cells.

Treatment Improves Mesothelioma Survival in Trial

An innovative treatment significantly increases the survival of people with malignant mesothelioma, according to results from a clinical trial.
A person looks down from space towards the Earth.

The Next Chapter of Science

Join us as we explore how innovation, ethics and even aesthetics look set to influence the landscape of life science research, creating new possibilities for treating human diseases, feeding our growing population and nurturing the scientists of the future.
Two researchers in a lab.

Study Paves the Way for More Effective Liver Cancer Immunotherapies

A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease.
Pink pills spill from a prescription bottle.

Cocaine Addiction Drug Could Pave Way for Colon Cancer Treatment

Vanoxerine, a drug initially developed to treat cocaine addiction, has also shown promise for advanced colon cancer in a new study.
Lung cancer cells.

Novel Combination Therapy Effective in Treating Immunotherapy-Resistant Lung Cancer

Phase II trial finds durvalumab plus ceralasertib boosted immune response and improved outcomes in patients with lung cancer.
Cell therapy.

Novel Design Improves CAR T-Cell Therapy for Childhood Leukemia

Scientists at St. Jude Children’s Research Hospital improved bispecific chimeric antigen receptor (CAR) T–cell immunotherapies for acute myeloid leukemia (AML), corroborated by computational analysis.
Computer-generated image of cells.

Risk of Secondary Cancer Investigated After CAR T-Cell Therapy

A study by University of Pennsylvania researchers shows that secondary cancer development is rare after CAR T-cell therapy and that many patients have achieved long-lasting remission.
T cells.

Technique Makes T Cells 100 Times More Potent at Killing Cancer Cells

Current immunotherapies work only against cancers of the blood and bone marrow. T cells engineered by Northwestern and UCSF were able to kill tumors derived from skin, lung and stomach in mice.